In our study, we found that the NF-κB-94 ins/del ATTG polymorphism is not a susceptible factor for MM, but MM patients with the NF-κB-94 ins/del ATTG del/del genotype had the highest myeloma cell ratio compared with ins/ins and ins/del patients. The gene discussed is NFKB1; the disease is plasma cell myeloma.